Drug safety
Greenwich Rx recalls compounded sterile products over sterility concerns
Consumers and clinics should stop using and discard recalled products, which could cause serious infections if they are not sterile.

Greenwich Rx is voluntarily recalling specific lots of compounded sterile products because of a potential lack of sterility assurance. The company said the concerns arose after an FDA inspection and its evaluation of the affected products. Greenwich Rx said it has found no evidence of contamination and has received no reports of adverse events related to the recall.
The products were dispensed nationwide between August 10, 2026 and September 21, 2026. Some were compounded by Greenwich Rx for another pharmacy, Clove Rx. Customers of both pharmacies should compare medication labels with the affected product list. Clove Rx customers should check the list even if they have not received a direct notice. Greenwich Rx is notifying its affected customers by mail.
Consumers and clinics with a recalled product should stop using it immediately and discard it. Greenwich Rx said use of a drug intended to be sterile that is not sterile could cause serious infections, which may be life threatening.


